Announce Date | 08/14/2025 |
EPS Normalized Actual | $-0.46 In Line |
EPS GAAP Actual | $-0.46 In Line |
Revenue Actual | $0.00165769B |
Revenue Surprise | Beat by $1.65769M |
Announce Date | 12/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.345 |
EPS GAAP Estimate | $-0.345 |
Revenue Estimate | $0.0059625B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 34.75 | 0.22 | 34.12191 | 35.37809 | 1 |
Dec 2027 | 24.75 | 0.3 | 24.30265 | 25.19735 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.65 | 0.19 | 0.00165769B | 100% | 0.71M |
FQ1 2025 (Mar 2025) | -0.13 | 0.45 | 0.00292865B | 100% | 2.43M |
FQ1 2020 (Jan 2020) | -0.0049 | -0.0049 | 0B | NAN% | 0M |
FQ1 2021 (Mar 2021) | -7 | -7 | 0B | NAN% | 0M |
FQ2 2021 (Jun 2021) | 0.0572 | 0.0572 | 0B | NAN% | 0M |
FQ3 2021 (Sep 2021) | -2.07 | -2.07 | 0B | NAN% | 0M |
FQ4 2021 (Dec 2021) | 0 | 0 | 0B | NAN% | 0M |
FQ1 2022 (Mar 2022) | -1 | -1 | 0B | NAN% | 0M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.345
Consensus Revenue Estimates
0.0059625B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | -0.135 | -- | -0.14461 | -0.12531 | 1 |
FQ3 2026 (Sep 2026) | -0.49 | -- | -0.49 | -0.49 | 1 |
FQ2 2026 (Jun 2026) | -0.59 | -10.17 | -0.59 | -0.59 | 1 |
FQ1 2026 (Mar 2026) | -0.35 | 62.86 | -0.37492 | -0.32487 | 1 |
FQ4 2025 (Dec 2025) | -0.345 | -- | -0.40414 | -0.276 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ3 2026 (Sep 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ2 2026 (Jun 2026) | 0.01B | 75.09 | 0.01B | 0.01B | 1 |
FQ1 2026 (Mar 2026) | 0.01B | 53.93 | 0.01B | 0.01B | 1 |
FQ4 2025 (Dec 2025) | 0.01B | -- | 0.01B | 0.01B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
2
Revenue # of Misses
0
Revenue # of in-lines
6
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.84 | -0.65 | 0.19 | -29.23% |
FQ1 2025 (Mar 2025) | -0.58 | -0.13 | 0.45 | -346.15% |
FQ1 2020 (Jan 2020) | -0.0049 | -0.0049 | 100% | |
FQ1 2021 (Mar 2021) | -7 | -7 | 100% | |
FQ2 2021 (Jun 2021) | 0.0572 | 0.0572 | 100% | |
FQ3 2021 (Sep 2021) | -2.07 | -2.07 | 100% | |
FQ4 2021 (Dec 2021) | 0 | 0 | NAN% | |
FQ1 2022 (Mar 2022) | -1 | -1 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $0B | $0.71M | 42.69% |
FQ1 2025 (Mar 2025) | $0B | $0B | $2.43M | 82.93% |
FQ1 2020 (Jan 2020) | $0B | $0B | $0M | NAN% |
FQ1 2021 (Mar 2021) | $0B | $0B | $0M | NAN% |
FQ2 2021 (Jun 2021) | $0B | $0B | $0M | NAN% |
FQ3 2021 (Sep 2021) | $0B | $0B | $0M | NAN% |
FQ4 2021 (Dec 2021) | $0B | $0B | $0M | NAN% |
FQ1 2022 (Mar 2022) | $0B | $0B | $0M | NAN% |